Filing Details
- Accession Number:
- 0001493152-20-004195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-18 10:50:00
- Reporting Period:
- 2020-03-17
- Accepted Time:
- 2020-03-18 10:50:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582554 | Matinas Biopharma Holdings Inc. | MTNB | Pharmaceutical Preparations (2834) | 463011414 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698838 | D Jerome Jabbour | C/O Matinas Biopharma Holdings, Inc. 1545 Route 206 South Suite 302 Bedminster, NJ 07921 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2020-03-17 | 10,000 | $0.65 | 799,511 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.64 to $0.65, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
